News Articles

Research shows remdesivir treatment for COVID-19 has little impact on survival, increases hospital stay

A new study finds that remdesivir, the first new medicine approved for treatment of COVID-19, is not associated with improved survival, but is associated with longer hospital stays for patients.

Gauging COVID-19 vaccine interest among adolescents, parents

In mid-May, the Food and Drug Administration (FDA) expanded the emergency use authorization (EUA) for the Pfizer-BioNTech Vaccine (Comiranty) to include adolescents ages 12 through 15.